<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03663426</url>
  </required_header>
  <id_info>
    <org_study_id>RCT impact OFA on THP</org_study_id>
    <nct_id>NCT03663426</nct_id>
  </id_info>
  <brief_title>Impact of Opioid Free Anesthesia on Outcome After Hip Arthroplasty by Direct Anterior Approach.</brief_title>
  <official_title>Randomized Controlled Trial Study in Hip Arthroplasty by Direct Anterior Approach Using Opioid Free Anesthesia (OFA) Versus Standard Opioid Anesthesia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AZ Sint-Jan AV</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AZ Sint-Jan AV</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      all patients with a first anterior arthroplasty, give their informed consent to be randomized
      to control or study protocol.

      control means no high steroid dose, opioids for anesthesia; paracetamol, NSAIDs and opioids
      as analgesia.

      study protocol means methylprednisolone 125 mg and opioid free anesthesia followed by
      paracetamol, NSAIDs and if needed opioids as escape.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      study group means for Anesthesia:

        1. High dose corticoids pre-operative: 125 mg Methylprednisolone. (Medrol) pre incision and
           24h postoperative

        2. OFA using a multimodal approach including alpha2agonists, lidocaine and low dose
           ketamine (max 1mg/kg).

        3. Avoid opioids post-operative by using multimodal non-opioid analgesics after OFA. Avoid
           epidural to allow rapid mobilization.

      all patients get Tranexamic acid 1 g (2 amp Exacyl 500mg) before and 1 g after surgery. It
      act as antifibrinolytic to reduce postoperative bleeding. (reversibly binding to lysine
      receptor sites on plasminogen) Try to give Continuous deep neuromuscular block (NMB) with a
      post titanic count (PTC) &lt; 3 by continuous infusion and monitoring of NMB.

      Intravenous Fluid restrictions to 1 ml/kg/h as long as pulse pressure (or plethysmograph)
      variation &lt; 20% to reduce wound edema.

      The pericapsular injections of local anesthetic, provided the patient had no
      contraindications such as poor renal function or allergies. 100 ml Ropivacaine 0,2% (max dose
      3 mg/kg) + additives (Adrenaline 2,5 cc) (Ropivacaine: max 3 mg/kg)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Actual">November 1, 2019</completion_date>
  <primary_completion_date type="Actual">October 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>QoR15</measure>
    <time_frame>measured at 24 hours after surgery.</time_frame>
    <description>quality of recovery (QoR15) measured by 15 questions evaluating condition of recovery) scale 0 to 15 with 0 being very bad while 15 being maximum recovery possible or equal to pre operative state.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>opioids postoperative</measure>
    <time_frame>measured at 24 hours after surgery.</time_frame>
    <description>opioid use postoperative at 24 hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CRP</measure>
    <time_frame>measured at 24 hours after surgery.</time_frame>
    <description>Chronic reactive protein (CRP) change 24 h post-operative</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>surgical condition</measure>
    <time_frame>after surgery</time_frame>
    <description>surgeon scores the surgical conditions on an adapted five-point Leyden scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle damage</measure>
    <time_frame>after surgery</time_frame>
    <description>surgeon scores the muscle damage on an adapted five-point Leyden scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of hospital stay</measure>
    <time_frame>until hospital discharge, maximum 7 days after surgery.</time_frame>
    <description>number days patient stay in the hospital before discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications</measure>
    <time_frame>2 weeks postoperative</time_frame>
    <description>complications up to two weeks postoperative</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Hip Arthropathy</condition>
  <arm_group>
    <arm_group_label>control group opioid anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard anesthesia using opioids</description>
  </arm_group>
  <arm_group>
    <arm_group_label>study group opioid free anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>opioid free anesthesia and high dose glucocorticoids</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>study group</intervention_name>
    <description>High dose corticoids pre-operative and 24h postoperative
Opioid free general anesthesia
Avoid opioids post-operative by continue clonidine, ketamine and lidocaine, only exceptional opioids after NSAID and paracetamol.</description>
    <arm_group_label>study group opioid free anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>control</intervention_name>
    <description>No corticoids pre-operative.
Opioid anesthesia
Opioids post-operative after NSAID and paracetamol.</description>
    <arm_group_label>control group opioid anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  arthroplasty by anterior approach

        Exclusion Criteria:

          -  allergy or impossible to use any of the drugs included

          -  revision procedure

          -  major cardiovascular, pulmonary or renal insufficiency requiring planned post
             operative intensive care admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco Lanckneus, MD</last_name>
    <role>Study Director</role>
    <affiliation>AZSint Jan AV</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azsintjan</name>
      <address>
        <city>Brugge</city>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>September 4, 2018</study_first_submitted>
  <study_first_submitted_qc>September 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2018</study_first_posted>
  <last_update_submitted>November 17, 2019</last_update_submitted>
  <last_update_submitted_qc>November 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>AZ Sint-Jan AV</investigator_affiliation>
    <investigator_full_name>Jan Mulier</investigator_full_name>
    <investigator_title>head of dep anesthesia &amp; intensive care</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

